BELLBROOK LABS LLC
- MADISON, WI 53717-1960
- bellbrooklabs.com (company website, opens in a new tab)
- Partnership or Limited Liability Partnership
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 0
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
BELLBROOK LABS LLC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About BELLBROOK LABS LLC
- Headquarters
- MADISON, WI 53717-1960
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEITUY5ZNJNHMC1
- CAGE46M41
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
No federal prime awards on record
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 36 awards
- Total awarded
- $17,466,478
- By phase
- SBIR Phase I: 22
- SBIR Phase II: 11
- STTR Phase I: 3
- By agency
- Department of Health and Human Services: 35
- Department of Commerce: 1
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2024: 1
- 2021: 1
- 2020: 1
- 2019: 1
- 2018: 1
- 2017: 1
- 2016: 3
- 2015: 2
- 2014: 2
- 2012: 1
- 2011: 1
- 2010: 3
- 2009: 4
- 2008: 3
- 2007: 3
- 2006: 2
- 2005: 3
- 2003: 1
- 2002: 2
Awards (most recent first)
Chemically Induced Dimerization Systems for High Throughput Enzyme Assays
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $270,929
Sep 20, 2024 – Sep 19, 2025
Solicitation PA23-230 (2023) · Topic 400
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2021 · $1,821,270
Feb 17, 2021 – Jan 31, 2023
Solicitation PA20-260 (2020) · Topic NIAID
Discovery of TREX1 Antagonists for Cancer Immunotherapy
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $300,000
Sep 11, 2020 – Aug 31, 2021
Solicitation PA19-272 (2019) · Topic 102
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $300,000
Jun 12, 2019 – Feb 28, 2021
Solicitation PA18-574 (2018) · Topic NIAID
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2018 · $1,337,035
May 1, 2018 – Apr 30, 2021
Solicitation PA17-302 (2017) · Topic 300
HTS Assays for Targeting the cGAS STING Pathway in Autoimmune Diseases and Cancer
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $288,683
May 1, 2017 – Apr 30, 2018
Solicitation PA16-302 (2016) · Topic 300
Pharmacological Validation of GIV/Girdin, a Guanine Nucleotide Exchange Factor, for Liver Fibrosis
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $353,332
Sep 20, 2016 – Aug 31, 2018
Solicitation PA15-269 (2015) · Topic N
Streamlining HTS Assay Development through Direct Selection of Structure-Switching Aptamers
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $234,936
Sep 13, 2016 – Mar 31, 2019
Solicitation PA15-270 (2015) · Topic 300
Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2016 · $860,676
May 1, 2016 – Apr 30, 2019
Solicitation PA15-269 (2015) · Topic 300
Axonal Transport HTS Platform for Neurodegeneration Drug Discovery
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $225,000
Jun 1, 2015 – May 31, 2017
Solicitation PA14-072 (2015) · Topic 106
Fluorescent biosensors for dynamic monitoring of paracrine signaling in extracellular matrix
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $224,999
Apr 1, 2015 – Dec 31, 2016
Solicitation PA14-071 (2015) · Topic 106
Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $224,931
Solicitation PA13-088 (2014) · Topic NIGMS · Research partner: Stub
HHSN261201400010C;TOPIC 328 - 3D TISSUE CULTURE SYSTEM FOR TUMOR MICROENVIRONMENT;TITLE: NOVEL AGENTS FOR CANCER DIAGNOSIS AND TARGETED THERAPY; 9 MONTHS FUNDING-PHASE I; CONTRACT PERFORMANCE PERIOD
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $225,000
Solicitation year 2014 · Topic NCI · Research partner: Stub
Screening Device for Differentiated Primary Cell Models of Airway Epithelia
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2012 · $733,586
Solicitation PA11-096 (2012) · Topic NHLBI · Research partner: Stub
High Throughput Assay for Detecting Protein Modifications in Cell Lysates
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2011 · $266,465
Solicitation PA10-050 (2011) · Topic NIGMS · Research partner: Stub
Intramolecular Immunoassay for Probing Paracrine Signaling
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2010 · $250,859
Solicitation PHS2010-2 (2010) · Topic NIGMS
A Highly Miniaturized Device For Fully Differentiated, Primary Cell Models of Air
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2010 · $391,927
Solicitation PHS2010-2 (2010) · Topic NHLBI
Development of MicroFluidic Palette for Cellular Responses to Chemical Stimuli
SBIR Phase I · Department of Commerce (National Institute of Standards and Technology) · 2010 · $90,000
Pharmacological Impact of 3-Dimensional Extracellular Matrix on Tumor Cells
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2009 · $198,120
Solicitation PHS2009-2 (2009)
Enhanced ADP Immunoassay for Multimode Kinase Detection
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2009 · $192,952
Solicitation PHS2009-2 (2009)
A microfluidic chemotaxis device for high content screening
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2009 · $963,340
Solicitation PHS2009-2 (2009)
HTS Assays for Modulators of GPCR Signaling
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2009 · $1,372,970
Solicitation PHS2009-2 (2009)
Microfluidic Viral Infection Assay
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2008 · $597,880
Solicitation PHS2007-2 (2008)
Generic Fluorescent HTS Assay for Oxidoreductases
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2008 · $210,100
Solicitation PHS2007-2 (2008)
Fluorescent HTS Assays for Methyltransferases in Neurodegenerative Diseases
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2008 · $822,148
Solicitation PHS2007-2 (2008)
Showing the 25 most recent of 36 awards.
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)PrimarySmall business under this code’s size standard
SAM.gov reports this entity as small under 1 of 1 NAICS code. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with BELLBROOK LABS LLC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.